Table 4.
Adherence to monitored bed observation and therapy. At the top, the analytic subgroups for the primary outcome. Below, the subgroups analyzed in the secondary outcomes.
| Adherence to Monitored Bed Observation and Therapy | Adherence to Monitored Bed Observation and Therapy | Yes (%) | No (%) | p |
|---|---|---|---|---|
| Primary endpoint | High-intensity care area | 70 | 30 | 0.495 |
| Low-intensity care area | 54 | 46 | ||
| OBI | 91 | 9 | 0.004 | |
| Not-OBI | 62 | 38 | ||
| Secondary endpoints | With organ damage (OD) | 60 | 40 | 0.101 |
| Without OD | 63 | 37 | ||
| Massive PE | 57 | 43 | 0.506 | |
| Peripheral PE | 56 | 44 | ||
| Typical symptoms | 61 | 39 | 0.455 | |
| Atypical symptoms | 62 | 38 |